| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2222.2006.02499.X |
| P698 | PubMed publication ID | 16776679 |
| P2093 | author name string | Leonardi A | |
| Zhan H | |||
| Curnow SJ | |||
| Calder VL | |||
| P2860 | cites work | Human chemokines: an update | Q28237635 |
| Progressive differentiation and selection of the fittest in the immune response | Q35014086 | ||
| Chemokines in the limbal form of vernal keratoconjunctivitis | Q35313078 | ||
| The eye and the eosinophil | Q40605370 | ||
| The role of conjunctival epithelial cells in chronic ocular allergic disease | Q40829833 | ||
| Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases | Q40835265 | ||
| Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease | Q40932149 | ||
| The T-lymphocyte chemoattractant Mig is highly expressed in vernal keratoconjunctivitis | Q42452173 | ||
| Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents | Q42651666 | ||
| Inflammatory cytokine of basal and reflex tears analysed by multicytokine assay | Q42842980 | ||
| No apparent association between periocular and ocular microcolonization and the degree of inflammation in patients with atopic keratoconjunctivitis | Q47602662 | ||
| Procollagens and inflammatory cytokine concentrations in tarsal and limbal vernal keratoconjunctivitis | Q47693980 | ||
| Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. | Q54797703 | ||
| Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis | Q73094358 | ||
| Synergistic effect of TNF-alpha and IL-4 on the expression of thymus- and activation-regulated chemokine in human corneal fibroblasts | Q73287017 | ||
| Tear levels of interferon-gamma, interleukin (IL) -2, IL-4 and IL-5 in patients with vernal keratoconjunctivitis, atopic keratoconjunctivitis and allergic conjunctivitis | Q73293753 | ||
| Tear and serum soluble leukocyte activation markers in conjunctival allergic diseases | Q73465756 | ||
| Simultaneous measurement of six cytokines in a single sample of human tears using microparticle-based flow cytometry: allergics vs. non-allergics | Q74019442 | ||
| Histamine effects on conjunctival fibroblasts from patients with vernal conjunctivitis | Q77901372 | ||
| Similar T helper Th2-like cytokine mRNA expression in vernal keratoconjunctivitis regardless of atopic constitution | Q77999504 | ||
| Inhibition of eotaxin expression in human corneal fibroblasts by interferon-gamma | Q78438802 | ||
| Alteration of tear cytokine balance by eye closure: analysis by multicytokine assay | Q81336407 | ||
| Alteration pattern of tear cytokines during the course of a day: diurnal rhythm analyzed by multicytokine assay | Q82236016 | ||
| P433 | issue | 6 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 777-784 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Clinical & Experimental Allergy | Q5133747 |
| P1476 | title | Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. | |
| P478 | volume | 36 |
| Q84135372 | Allergic conjunctivitis and nasal allergy |
| Q37249799 | Allergy and the eye. |
| Q42743183 | Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells |
| Q47624172 | Bead Based Multiplex Assay for Analysis of Tear Cytokine Profiles. |
| Q38951848 | Bilateral Alterations in Corneal Nerves, Dendritic Cells, and Tear Cytokine Levels in Ocular Surface Disease |
| Q37857747 | Causes and management of red eye in pediatric ophthalmology |
| Q37697882 | Cellular changes in tears associated with keratoconjunctival responses induced by nasal allergy |
| Q38633880 | Changes in Tear Cytokine Concentrations Following Discontinuation of Soft Contact Lenses-A Pilot Study. |
| Q34452944 | Changes to tear cytokines of type 2 diabetic patients with or without retinopathy |
| Q40267943 | Chaperone patterns in vernal keratoconjunctivitis are distinctive of cell and Hsp type and are modified by inflammatory stimuli |
| Q33514140 | Cleavage of functional IL-2 receptor alpha chain (CD25) from murine corneal and conjunctival epithelia by MMP-9. |
| Q51279666 | Clinical Severity and Tear Biomarkers, Eosinophil Cationic Protein and CCL23, in Chronic Allergic Conjunctival Diseases. |
| Q51297818 | Clinical Usefulness of Simultaneous Measurement of the Tear Levels of CCL17, CCL24, and IL-16 for the Biomarkers of Allergic Conjunctival Disorders. |
| Q37462649 | Conjunctival interleukin-13 expression in mucous membrane pemphigoid and functional effects of interleukin-13 on conjunctival fibroblasts in vitro |
| Q57266967 | Conjunctival provocation with airborne allergen in patients with atopic keratoconjunctivitis |
| Q34557837 | Correlation between human tear cytokine levels and cellular corneal changes in patients with bacterial keratitis by in vivo confocal microscopy. |
| Q43245699 | Cyclosporin A eye drops inhibit fibrosis and inflammatory cell infiltration in murine type I allergic conjunctivitis without affecting the early-phase reaction |
| Q48206476 | Cytokine and chemokine tear levels in patients with uveitis. |
| Q35178892 | Cytokine changes in tears and relationship to contact lens discomfort |
| Q37755206 | Cytokines and chemokines in immune-based ocular surface inflammation. |
| Q40482112 | Effects of carvedilol reduce conjunctivitis through changes in inflammation, NGF and VEGF levels in a rat model. |
| Q34999618 | Emerging drugs for conjunctivitis |
| Q92099712 | Evaluation of Chemokine mRNA Expression to Assess Allergic Inflammation of the Ocular Surface in Chronic Allergic Conjunctival Diseases |
| Q51743503 | Evaluation of eotaxin-1, -2, and -3 protein production and messenger RNA expression in patients with vernal keratoconjunctivitis. |
| Q35831266 | IL-13 Stimulates Proliferation and Expression of Mucin and Immunomodulatory Genes in Cultured Conjunctival Goblet Cells |
| Q35065054 | Identification of human tear fluid biomarkers in vernal keratoconjunctivitis using iTRAQ quantitative proteomics. |
| Q46620717 | Involvement of NFκB in the production of chemokines by rat and human conjunctival cells cultured under allergenic conditions |
| Q35847214 | Lacrimal Cytokines Assessment in Subjects Exposed to Different Levels of Ambient Air Pollution in a Large Metropolitan Area |
| Q38563744 | Linking immune responses with fibrosis in allergic eye disease |
| Q64095519 | Low Expression of IL-10 in Circulating Bregs and Inverted IL-10/TNF-α Ratio in Tears of Patients with Perennial Allergic Conjunctivitis: A Preliminary Study |
| Q37954005 | Management of seasonal allergic conjunctivitis: guide to therapy |
| Q37016912 | Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa |
| Q37629825 | Mediators of neovascularization and the hypoxic cornea |
| Q48473638 | Meibomian gland dysfunction and tear cytokines after cataract surgery according to preoperative meibomian gland status. |
| Q47594873 | Multiple cytokine analysis in human tears: an optimized procedure for cytometric bead-based assay |
| Q92540231 | New antihistamines - perspectives in the treatment of some allergic and inflammatory disorders |
| Q39365232 | Non-invasive objective and contemporary methods for measuring ocular surface inflammation in soft contact lens wearers - A review. |
| Q38040514 | Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. |
| Q37821002 | Ocular fungal infections |
| Q37716013 | Olopatadine: a drug for allergic conjunctivitis targeting the mast cell. |
| Q89875491 | Potential Biomarkers for Allergic Conjunctival Diseases |
| Q33735876 | Quantification of tear proteins and sPLA2-IIa alteration in patients with allergic conjunctivitis |
| Q36637480 | Quiescent and Active Tear Protein Profiles to Predict Vernal Keratoconjunctivitis Reactivation |
| Q37055011 | Release of membrane-associated mucins from ocular surface epithelia |
| Q57048591 | Resolvin D1 treatment on goblet cell mucin and immune responses in the chronic allergic eye disease (AED) model |
| Q61811294 | Review of Biomarkers in Ocular Matrices: Challenges and Opportunities |
| Q38060836 | Roles of IL-10 in ocular inflammations: a review. |
| Q33813133 | Subnormal cytokine profile in the tear fluid of keratoconus patients |
| Q94324354 | Systemic interventions for severe atopic and vernal keratoconjunctivitis in children and young people up to the age of 16 years |
| Q28393435 | Tear cytokine profile as a noninvasive biomarker of inflammation for ocular surface diseases: standard operating procedures |
| Q36637791 | Tear cytokine profiles in dysfunctional tear syndrome. |
| Q39153770 | Tear film inflammatory mediators in patients with keratoconus. |
| Q26740411 | Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine |
| Q51639647 | The Study of Interleukin-17 Level in Vernal Keratoconjunctivitis Disease and its Relationship between Symptom and Sign Severity. |
| Q41909205 | The anatomical and functional relationship between allergic conjunctivitis and allergic rhinitis |
| Q41899890 | Therapeutic targeting of eosinophil adhesion and accumulation in allergic conjunctivitis |
| Q92941357 | To See or Not to See: A Systematic Review of the Importance of Human Ocular Surface Cytokine Biosignatures in Ocular Allergy |
| Q34130473 | Total IgE and eotaxin (CCL11) contents in tears of patients suffering from seasonal allergic conjunctivitis |
| Q38910692 | Treating allergic conjunctivitis: A once-daily medication that provides 24-hour symptom relief |
| Q37037418 | Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders |
| Q38102592 | Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis |
Search more.